(PharmaNewsWire.Com, September 10, 2019 ) According to research report the global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%.Advancements in molecular cloning research due to the emergence of new technologies and increasing commercial demand for molecular cloned products and recombinant proteins are the major factors driving the growth of the competent cells market. The market is dominated by North America, followed by Europe. The North American region is expected to grow at the fastest CAGR during the forecast period. This is primarily due to increase in the R&D activities in the region. Download PDF Brochure: https://www.marketsandmarkets.com/requestsampleNew.asp?id=265815900 Thermo Fisher Scientific, Inc. is one of the key players in the competent cells market. The company focuses on product launches, acquisitions, and agreements to enhance its presence in the market. In January 2016, Thermo Fisher acquired Affymetrix (U.S.), to strengthen its leadership in biosciences and to create new market opportunities in genetic analysis. Similarly, in February 2014, the company acquired Life Technologies Inc. (U.S.). After this acquisition, Thermo Fisher created a new business segment—Life Sciences Solutions— which includes a broad range of protein expression systems and their related products. Merck KGaA accounted for the second largest share of the competent cells market in 2016. The company focuses on acquisitions and partnerships to maintain its leading position in the market. In November 2015, Merck KGaA acquired Sigma-Aldrich Co., LLC. (U.S.), an established player in the life science industry. Sigma-Aldrich offers a broad range of protein expression products. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=265815900 Product launches, acquisitions, and partnerships were some of the major strategies followed by key players in the competent cells market. These strategies were adopted by—Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), New England Biolabs (U.S.), GenScript Biotech Corporation (China), and Agilent Technologies, Inc. (U.S.).
Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 newsletter@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
